Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X B Shi

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
World Journal of Urology|January 1, 1996
Molecular biology of prostate cancerX B Shi, P H Gumerlock, R W deVere White
Carcinogenesis|July 27, 2000
3-Methylcholanthrene triggers the differentiation of alveolar tumor cells from canine bronchial basal cells and an altered p53 gene promotes their clonal expansionA A TenHave-Opbroek, X B Shi, P H Gumerlock
The Prostate|September 9, 1999
Use of a yeast assay to detect functional alterations in p53 in prostate cancer: review and future directionsR W deVere White, A D Deitch, P H Gumerlock, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 5, 2002
BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agentsX B Shi, P H Gumerlock, J T Muenzer, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|December 1, 1996
Identification of p53 mutations in archival prostate tumors. Sensitivity of an optimized single-strand conformational polymorphism (SSCP) assayX B Shi, S M Bodner, R W deVere White, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Efficient recombination of Lym-1 scFv gene using multiple doubly-restricted DNA fragmentsX B Shi, P H Gumerlock, L Kroger, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 29, 2009
Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese populationH Y Zhang, F F Zhu, J Xiong, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 16, 2002
Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: bispecific antibodies for pretargeted radioimmunotherapyD G DeNardo, C Y Xiong, X B Shi, et al.
Zhonghua Nei Ke Za Zhi|October 7, 2024
[Relationship between epilepsy and patent foramen ovale]X Zhang, C J Shao, D S Li, et al.
Oncogene|January 26, 2006
The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7R L Vinall, C G Tepper, X-B Shi, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
World Journal of Urology|January 1, 1996
Molecular biology of prostate cancerX B Shi, P H Gumerlock, R W deVere White
Carcinogenesis|July 27, 2000
3-Methylcholanthrene triggers the differentiation of alveolar tumor cells from canine bronchial basal cells and an altered p53 gene promotes their clonal expansionA A TenHave-Opbroek, X B Shi, P H Gumerlock
The Prostate|September 9, 1999
Use of a yeast assay to detect functional alterations in p53 in prostate cancer: review and future directionsR W deVere White, A D Deitch, P H Gumerlock, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 5, 2002
BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agentsX B Shi, P H Gumerlock, J T Muenzer, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|December 1, 1996
Identification of p53 mutations in archival prostate tumors. Sensitivity of an optimized single-strand conformational polymorphism (SSCP) assayX B Shi, S M Bodner, R W deVere White, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Efficient recombination of Lym-1 scFv gene using multiple doubly-restricted DNA fragmentsX B Shi, P H Gumerlock, L Kroger, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 29, 2009
Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese populationH Y Zhang, F F Zhu, J Xiong, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 16, 2002
Anti-HLA-DR/anti-DOTA diabody construction in a modular gene design platform: bispecific antibodies for pretargeted radioimmunotherapyD G DeNardo, C Y Xiong, X B Shi, et al.
Zhonghua Nei Ke Za Zhi|October 7, 2024
[Relationship between epilepsy and patent foramen ovale]X Zhang, C J Shao, D S Li, et al.
Oncogene|January 26, 2006
The R273H p53 mutation can facilitate the androgen-independent growth of LNCaP by a mechanism that involves H2 relaxin and its cognate receptor LGR7R L Vinall, C G Tepper, X-B Shi, et al.
Pageof 3